GlassScriptPhysician profile
Margaret A Wright
NPI 1801010020
$2,717.91
in general payments reported to CMS, 2019-2025
16 companies · $774 in 2025
The $774 reported for 2025 was more than what 98% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $306 · 2022: $736 · 2023: $493 · 2024: $408 · 2025: $774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,576 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,576.20 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $698.80 | 2021-2025 | |
| Abbott Laboratories | $379.40 | 2021-2024 | Xience Skypoint, Coroflow, Nc Trek Neo |
| Novo Nordisk INC | $304.62 | 2021-2023 | Wegovy |
| Lilly USA, LLC | $263.11 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $190.44 | 2022-2025 | Farxiga, Breztri |
| Amgen INC. | $184.64 | 2023-2025 | Otezla, Repatha, Otezla |
| Astellas Pharma US INC | $170.58 | 2023-2025 | Veozah |
| Pfizer INC. | $116.80 | 2022-2025 | |
| Indivior INC. | $88.76 | 2024-2025 | Sublocade |
| Medtronic, INC. | $75.89 | 2023 | Venaseal, Propel |
| Axsome Therapeutics, INC. | $61.75 | 2024-2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.75 | 2024-2025 | Jardiance |
| Exact Sciences Corporation | $43.76 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $42.64 | 2023-2024 | |
| Esperion Therapeutics, INC. | $29.38 | 2023-2025 | Nexletol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.